Antidiabetic phospholipid-nuclear receptor complex reveals the mechanism for phospholipid-driven gene regulation

Nature Structural and Molecular Biology

Volumn 19, Issue 5, 2012, Pages 532-537

  Musille, Paul M ^a   Pathak, Manish C ^a   Lauer, Janelle L ^b   Hudson, William H ^a   Griffin, Patrick R ^b   Ortlund, Eric A ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DILAUROYLPHOSPHATIDYLCHOLINE; LIVER RECEPTOR HOMOLOG 1;

ARTICLE; DEUTERIUM HYDROGEN EXCHANGE; DIABETES MELLITUS; GENE CONTROL; HUMAN; LIGAND BINDING; PRIORITY JOURNAL; THERMOSTABILITY;

CRYSTALLOGRAPHY, X-RAY; DIABETES MELLITUS; GENE EXPRESSION REGULATION; HUMANS; HYPOGLYCEMIC AGENTS; MOLECULAR DYNAMICS SIMULATION; NUCLEAR RECEPTOR CO-REPRESSOR 2; NUCLEAR RECEPTOR COACTIVATOR 2; PHOSPHATIDYLCHOLINES; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 84860733689     PISSN: 15459993     EISSN: 15459985     Source Type: Journal    
DOI: 10.1038/nsmb.2279     Document Type: Article

References (38)

1. Lee, J.M. et al. A nuclear-receptor-dependent phosphatidylcholine pathway with antidiabetic effects. Nature 474, 506-510 (2011).
2. Ortlund, E.A. et al. Modulation of human nuclear receptor LRH-1 activity by phospholipids and SHP. Nat. Struct. Mol. Biol. 12, 357-363 (2005).
3. Krylova, I.N. et al. Structural analyses reveal phosphatidyl inositols as ligands for the NR5 orphan receptors SF-1 and LRH-1. Cell 120, 343-355 (2005).
4. Li, Y. et al. Structural and biochemical basis for selective repression of the orphan nuclear receptor liver receptor homolog 1 by small heterodimer partner. Proc. Natl. Acad. Sci. USA 102, 9505-9510 (2005).
5. Fernandez-Marcos, P.J., Auwerx, J. & Schoonjans, K. Emerging actions of the nuclear receptor LRH-1 in the gut. Biochim. Biophys. Acta 1812, 947-955 (2011).
6. Lee, Y.K. & Moore, D.D. Liver receptor homolog-1, an emerging metabolic modulator. Front. Biosci. 13, 5950-5958 (2008).
7. Parker, K.L. & Schimmer, B.P. Steroidogenic factor 1: a key determinant of endocrine development and function. Endocr. Rev. 18, 361-377 (1997).
8. Wagner, R.T., Xu, X., Yi, F., Merrill, B.J. & Cooney, A.J. Canonical Wnt/beta-catenin regulation of liver receptor homolog-1 mediates pluripotency gene expression. Stem Cells 28, 1794-1804 (2010).
9. Gu, P. et al. Orphan nuclear receptor LRH-1 is required to maintain Oct4 expression at the epiblast stage of embryonic development. Mol. Cell Biol. 25, 3492-3505 (2005).
10. Clyne, C.D., Speed, C.J., Zhou, J. & Simpson, E.R. Liver receptor homologue-1 (LRH-1) regulates expression of aromatase in preadipocytes. J. Biol. Chem. 277, 20591-20597 (2002).
11. Clyne, C.D. et al. Regulation of aromatase expression by the nuclear receptor LRH-1 in adipose tissue. Mol. Cell Endocrinol. 215, 39-44 (2004).
12. Zhou, J. et al. Interactions between prostaglandin E-2, liver receptor homologue-1, and aromatase in breast cancer. Cancer Res. 65, 657-663 (2005).
13. Chand, A.L., Herridge, K.A., Thompson, E.W. & Clyne, C.D. The orphan nuclear receptor LRH-1 promotes breast cancer motility and invasion. Endocr. Relat. Cancer 17, 965-975 (2010).
14. Annicotte, J.S. et al. The nuclear receptor liver receptor homolog-1 is an estrogen receptor target gene. Oncogene 24, 8167-8175 (2005).
15. Thiruchelvam, P.T. et al. The liver receptor homolog-1 regulates estrogen receptor expression in breast cancer cells. Breast Cancer Res. Treat. 127, 385-396 (2011).
16. Nagy, L. & Schwabe, J.W. Mechanism of the nuclear receptor molecular switch. Trends Biochem. Sci. 29, 317-324 (2004).
17. Goodwin, B. et al. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol. Cell 6, 517-526 (2000).
18. Sablin, E.P. et al. The structure of corepressor Dax-1 bound to its target nuclear receptor LRH-1. Proc. Natl. Acad. Sci. USA 105, 18390-18395 (2008).
19. Sablin, E.P., Krylova, I.N., Fletterick, R.J. & Ingraham, H.A. Structural basis for ligand-independent activation of the orphan nuclear receptor LRH-1. Mol. Cell 11, 1575-1585 (2003).
20. Ingraham, H.A. & Redinbo, M.R. Orphan nuclear receptors adopted by crystallography. Curr. Opin. Struct. Biol. 15, 708-715 (2005).
21. Xu, P.L., Kong, Y.Y., Xie, Y.H. & Wang, Y. Corepressor SMRT specifically represses the transcriptional activity of orphan nuclear receptor hB1F/hLRH-1. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 35, 897-903 (2003).
22. Wang, W. et al. The crystal structures of human steroidogenic factor-1 and liver receptor homologue-1. Proc. Natl. Acad. Sci. USA 102, 7505-7510 (2005).
23. Li, Y. et al. Crystallographic identification and functional characterization of phospholipids as ligands for the orphan nuclear receptor steroidogenic factor-1. Mol. Cell 17, 491-502 (2005).
24. Gee, A.C. & Katzenellenbogen, J.A. Probing conformational changes in the estrogen receptor: evidence for a partially unfolded intermediate facilitating ligand binding and release. Mol. Endocrinol. 15, 421-428 (2001).
25. Yumoto, F. et al. Structural basis of coactivation of liver receptor homolog-1 by β-catenin. Proc. Natl. Acad. Sci. USA 109, 143-148 (2012).
26. Jasuja, R. et al. Kinetic and thermodynamic characterization of dihydrotestosterone-induced conformational perturbations in androgen receptor ligand-binding domain. Mol. Endocrinol. 23, 1231-1241 (2009).
27. Venteclef, N. et al. GPS2-dependent corepressor/SUMO pathways govern anti-inflammatory actions of LRH-1 and LXRbeta in the hepatic acute phase response. Genes Dev. 24, 381-395 (2010).
28. Whitby, R.J. et al. Small molecule agonists of the orphan nuclear receptors steroidogenic factor-1 (SF-1, NR5A1) and liver receptor homologue-1 (LRH-1, NR5A2). J. Med. Chem. 54, 2266-2281 (2011).
29. Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307-326 (1997).
30. Murshudov, G.N., Vagin, A.A. & Dodson, E.J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D Biol. Crystallogr. 53, 240-255 (1997).
31. Potterton, E., Briggs, P., Turkenburg, M. & Dodson, E. A graphical user interface to the CCP4 program suite. Acta Crystallogr. D Biol. Crystallogr. 59, 1131-1137 (2003).
32. Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126-2132 (2004).
33. Emsley, P., Lohkamp, B., Scott, W.G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486-501 (2010).
34. Chen, V.B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D Biol. Crystallogr. 66, 12-21 (2010).
35. Bligh, E.G. & Dyer, W.J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911-917 (1959).
36. Zhou, X. & Arthur, G. Improved procedures for the determination of lipid phosphorus by malachite green. J. Lipid Res. 33, 1233-1236 (1992).
37. Louis-Jeune, C., Andrade-Navarro, M.A. & Perez-Iratxeta, C. Prediction of protein secondary structure from circular dichroism using theoretically derived spectra. Proteins published online, doi:10.1002/prot.23188 (14 September 2011).
38. Chalmers, M.J. et al. Probing protein ligand interactions by automated hydrogen/deuterium exchange mass spectrometry. Anal. Chem. 78, 1005-1014 (2006).